Search research articles
Contact Us
Filters
Showing results (11-20 of 18) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 18 results.
Cancer Research
|
June 24, 2000
Genetically modified dendritic cells prime autoreactive T cells through a pathway independent of CD40L and interleukin 12: implications for cancer vaccines
Y Wan, J Bramson, A Pilon, et al.
Gene Therapy
|
February 7, 2003
Enabling topical immunization via microporation: a novel method for pain-free and needle-free delivery of adenovirus-based vaccines
J Bramson, K Dayball, C Evelegh, et al.
Human Gene Therapy
|
February 10, 1996
Construction of a double recombinant adenovirus vector expressing a heterodimeric cytokine: in vitro and in vivo production of biologically active interleukin-12
J Bramson, M Hitt, W S Gallichan, et al.
Mutation Research
|
May 1, 1995
Nitrogen mustard drug resistant B-cell chronic lymphocytic leukemia as an in vivo model for crosslinking agent resistance
J Bramson, A McQuillan, R Aubin, et al.
Cancer Research
|
November 15, 1993
Poly(ADP-ribose) polymerase can bind melphalan damaged DNA
J Bramson, J Prévost, A Malapetsa, et al.
Journal of the National Cancer Institute
|
April 17, 1991
Increased DNA synthesis and repair-enzyme expression in lymphocytes from patients with chronic lymphocytic leukemia resistant to nitrogen mustards
R Geleziunas, A McQuillan, A Malapetsa, et al.
Shock (Augusta, Ga.)
|
November 15, 1997
Anti-interleukin-12 therapy protects mice in lethal endotoxemia but impairs bacterial clearance in murine Escherichia coli peritoneal sepsis
D A Zisman, S L Kunkel, R M Strieter, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
October 1, 1996
IL-12 gene therapy protects mice in lethal Klebsiella pneumonia
M J Greenberger, S L Kunkel, R M Strieter, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 18) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 18 results.
Cancer Research
|
June 24, 2000
Genetically modified dendritic cells prime autoreactive T cells through a pathway independent of CD40L and interleukin 12: implications for cancer vaccines
Y Wan, J Bramson, A Pilon, et al.
Gene Therapy
|
February 7, 2003
Enabling topical immunization via microporation: a novel method for pain-free and needle-free delivery of adenovirus-based vaccines
J Bramson, K Dayball, C Evelegh, et al.
Human Gene Therapy
|
February 10, 1996
Construction of a double recombinant adenovirus vector expressing a heterodimeric cytokine: in vitro and in vivo production of biologically active interleukin-12
J Bramson, M Hitt, W S Gallichan, et al.
Mutation Research
|
May 1, 1995
Nitrogen mustard drug resistant B-cell chronic lymphocytic leukemia as an in vivo model for crosslinking agent resistance
J Bramson, A McQuillan, R Aubin, et al.
Cancer Research
|
November 15, 1993
Poly(ADP-ribose) polymerase can bind melphalan damaged DNA
J Bramson, J Prévost, A Malapetsa, et al.
Journal of the National Cancer Institute
|
April 17, 1991
Increased DNA synthesis and repair-enzyme expression in lymphocytes from patients with chronic lymphocytic leukemia resistant to nitrogen mustards
R Geleziunas, A McQuillan, A Malapetsa, et al.
Shock (Augusta, Ga.)
|
November 15, 1997
Anti-interleukin-12 therapy protects mice in lethal endotoxemia but impairs bacterial clearance in murine Escherichia coli peritoneal sepsis
D A Zisman, S L Kunkel, R M Strieter, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
October 1, 1996
IL-12 gene therapy protects mice in lethal Klebsiella pneumonia
M J Greenberger, S L Kunkel, R M Strieter, et al.
Page
of 2